Roxanol and Arthritis - a phase IV clinical study of FDA data

Summary:

Arthritis is reported as a side effect among people who take Roxanol (morphine sulfate), especially for people who are male, 60+ old, also take Zometa, and have Metastases to bone.

The phase IV clinical study analyzes which people have Arthritis when taking Roxanol. It is created by eHealthMe based on reports of 804 people who have side effects when taking Roxanol from the FDA, and is updated regularly.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.

What is Arthritis?

Arthritis (form of joint disorder that involves inflammation of one or more joints) is found to be associated with 1,962 drugs and 2,259 conditions by eHealthMe. Check the latest studies of Arthritis.

On Jul, 19, 2026

804 people reported to have side effects when taking Roxanol.
Among them, 27 people (3.36%) have Arthritis.

Among these 27 people:

What is the gender of people who have Arthritis when taking Roxanol? *

female: 19.23 %
male: 80.77 %

What is the age of people who have Arthritis when taking Roxanol? *

What are other drugs people take besides Roxanol? *

What are other side effects people have besides Arthritis? *

Stress And Anxiety: 27 people, 100.00%
Pain: 26 people, 96.30%
Weakness: 26 people, 96.30%
Osteonecrosis Of Jaw (death of bone of jaw): 24 people, 88.89%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 21 people, 77.78%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 20 people, 74.07%
Back Pain: 20 people, 74.07%
Multiple Myeloma (cancer of the plasma cells): 20 people, 74.07%
Injury: 19 people, 70.37%
Depression: 18 people, 66.67%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 13 people, 48.15%
Multiple Myeloma (cancer of the plasma cells): 12 people, 44.44%
Stress And Anxiety: 3 people, 11.11%
Osteoporosis (bones weak and more likely to break): 2 people, 7.41%
Pain: 1 person, 3.70%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 3.70%
Lung Neoplasm Malignant (cancer tumour of lung): 1 person, 3.70%
Hepatitis C: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Roxanol and have Arthritis?

- Check whether Arthritis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxanol:

Roxanol (807 reports)

Arthritis treatments and more:

Arthritis (188,667 reports)

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arthritis:

Arthritis (1,962 drugs)

Browse all the conditions that are associated with Arthritis:

Arthritis (2,259 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Roxanol) and Roxanol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.